Zhejiang Hisun Pharmaceutical Co., Ltd. (SHA:600267)
China flag China · Delayed Price · Currency is CNY
11.93
+0.21 (1.79%)
Jul 29, 2026, 1:35 PM CST

SHA:600267 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
10,30810,55010,34010,37312,03712,136
Revenue Growth
0.61%2.02%-0.32%-13.82%-0.82%6.89%
Gross Profit
4,7194,6124,1544,0354,9184,806
Operating Income
1,1351,085657.14316.55956.29855.41
Net Income
702.17540.71601.18-93.17488.86486.89
Earnings Per Share
0.600.460.52-0.080.420.43
EPS Growth
25.04%-11.54%---2.33%0%

Revenue by Segment

Fiscal YearFY 2025
Period EndingDec '25
Pharmaceutical Manufacturing
6,497
Pharmaceutical Business
3,897
CMO/CDMO/CRO Business
7.8
Others
18.93
Total
10,421

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,8571,2951,4981,5871,3991,299
Total Debt
2,2232,9404,1505,6136,4197,855
Net Cash (Debt)
-366.14-1,645-2,652-4,026-5,020-6,556
Net Cash Growth
------
Net Cash Per Share
-0.31-1.40-2.29-3.46-4.31-5.79

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
2,2202,0322,1841,5032,0661,737
Capital Expenditures
-455.31-376.4-238.44-240.04-530.62-622.38
Free Cash Flow
1,7641,6551,9461,2631,5351,114
Free Cash Flow Growth
-6.09%-14.92%54.10%-17.75%37.78%24.13%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
45.77%43.71%40.17%38.90%40.86%39.60%
Operating Margin
11.02%10.28%6.35%3.05%7.95%7.05%
Pretax Margin
10.17%7.73%6.94%-0.80%5.68%5.31%
Profit Margin
6.81%5.13%5.81%-0.90%4.06%4.01%
FCF Margin
17.12%15.69%18.82%12.17%12.75%9.18%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.2100.2100.210-0.1700.140
Dividend Per Share Growth
0%0%--21.43%182.26%
Dividend Yield
1.77%2.17%2.65%-1.64%1.07%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
19.6421.2816.14-26.4634.37
Forward PE
24.9423.27207.50156.00160.67160.67
P/FCF Ratio
7.696.954.998.828.4315.02
PS Ratio
1.321.090.941.071.081.38